CONTENTS:
- Pilot testing an asynchronous online harm reduction and pharmacotherapy stigma reduction training for substance use treatment professionals. Sulzer S.H., Prevedel S., Barrett T.S., Mekjian M., Vincent M., Frabis F., et al., p. 327-339.
- Who is in, for how long and what for. Exploring the social dimension of cannabis social clubs in Barcelona, 2017-2020. Obradors-Pineda A., Bouso J.C., Colom J., Manthey J., p. 340-356.
- Daily cannabis use: Do impulsivity and sensation seeking predict negative cannabis related consequences? Parnes J.E., Tyskiewicz A.J., Prince M.A., Conner B.T., p. 357-364.
- Context of substance use: Harm reduction and safer supply. Haines M., O'Byrne P., p. 365-378.
- Strong control and weak service: Enforcing drug treatment in China. Jiang J., Song A., p. 379-400.
- Attitudes and subjective norms regarding medication for opioid use disorder among individuals in treatment for opioid use disorder in the greater St. Louis Area. Filiatreau L.M., Szlyk H.S., Kasson E., Dickson M.F., Banks D., Winograd R., et al., p. 401-419.
- A feasibility and acceptability study using ecological momentary assessment to evaluate drug use patterns among midwestern people who use drugs. Tyler K.A., Eisenbraun A.R., Habecker P., Khan B., p. 420-433.
- HCV medication receipt among individuals with methamphetamine, opioid, and alcohol use disorders in Arkansas, 2018-2022: A long road ahead for HCV elimination in the US South. Pro G., Hayes C., Bona J., Gu M., Richoux C., Zaller N., p. 434-449.
- Tests of social bonding, differential association/social learning, strain theories, and cigarette use among adolescents in Türkiye. Ozbay O., Zeybekoglu Akbas O., Kokturk G.V., p. 450-474.
- Implementing harm reduction-based medical assistance via an online platform for people who use drugs in Russia: A qualitative study. Davitadze A., Meylakhs P., Rodionova T., Lakhov A., p. 475-491.